2025.08.25
Notice of Resignation of Representative Director Keiichi Masuya and New Management Structure
August 25, 2025
J-Pharma Co.,Ltd.
J-Pharma Co., Ltd. announces that Dr. Keiichi Masuya has resigned from his position as Representative Director and Director of the Company, effective August 25, 2025, due to personal reasons. We would also like to report the new management structure as outlined below.
New management structure (as of August 25, 2025)
Position | Name |
Representative Director & President/ CEO | Masuhiro Yoshitake |
Director & Chief Financial Officer(CFO) | Yutaka Fujimoto |
External Director | Yasuo Miura |
External Director | Sadashi Suzuki |
External Director | Shinichiro Komoto |
External Director | Kazunobu Nishimura |
External Director | Takuma Tsuzuku |
External Director, Audit & Supervisory Committee | Toshiyuki Mori |
External Director, Audit & Supervisory Committee | Teruhisa Tajima |
External Director, Audit & Supervisory Committee | Kosaku Kawaguchi |
Inquiries:
J-Pharma Co., Ltd.
Planning Department
TEL : +81-3-6432-4270
https://www.j-pharma.com/en/contact